Multimorbidity Care: Doctor Experiences Point

Medically reviewed | Published: | Evidence level: 1A
A Scientific Reports qualitative study on physicians managing multimorbidity across the COVID-19 pandemic in Odisha, India, adds to evidence that chronic disease care can become fragile when follow-up, prescribing and communication are disrupted. The findings are especially relevant as WHO data show noncommunicable diseases remain the dominant global cause of death.
📅 Published:
Reviewed by iMedic Medical Editorial Team
📄 Public Health

Quick Facts

NCD Deaths
43 million
Before Age 70
18 million deaths
Main NCD Groups
4 disease groups

Why Is Multimorbidity So Hard to Manage in Primary Care?

Quick answer: Multimorbidity is difficult because each condition may have its own medicines, monitoring needs and specialist advice, while the patient experiences them as one daily health burden.

Multimorbidity means living with two or more long-term conditions, such as diabetes, hypertension, heart disease, chronic kidney disease, asthma, depression or arthritis. For clinicians, the challenge is not simply adding one diagnosis to another; it is deciding which problems need priority, which treatments interact and how to avoid overwhelming the patient with fragmented instructions.

The new Scientific Reports study focuses on physician experience, an important but sometimes underused source of health-system evidence. Qualitative research does not measure treatment effects the way a randomized trial does, but it can show where care breaks down: missed appointments, unclear referral pathways, medication changes made by different clinicians and limited time to discuss lifestyle, mental health and social barriers.

What Did Pandemic-Era Care Reveal About Chronic Disease Follow-Up?

Quick answer: Pandemic-era care showed that patients with several chronic conditions need reliable continuity, medication review and clear communication even when routine services are disrupted.

During the COVID-19 pandemic, many health systems had to reduce routine visits, shift resources and rely more heavily on phone-based or delayed care. For people with multimorbidity, that kind of disruption can be especially risky because blood pressure, glucose control, breathing symptoms, kidney function and medication side effects often need repeated monitoring rather than one-time treatment.

The broader lesson is not limited to one country or one emergency period. WHO emphasizes that detecting, screening and treating noncommunicable diseases are core parts of primary care. When follow-up is weak, patients may receive duplicate medicines, conflicting advice or delayed escalation for warning signs such as chest pain, severe breathlessness, very high glucose readings or worsening depression.

How Can Health Systems Improve Care for Patients With Several Conditions?

Quick answer: Health systems can improve multimorbidity care by shifting from disease-by-disease visits to coordinated, person-centered care plans.

Practical improvements include shared medication lists, routine deprescribing reviews, longer appointments for complex patients, better referral feedback and care plans that name the patient's top goals. For example, an older adult with diabetes, hypertension and osteoarthritis may care most about staying mobile and avoiding dizziness from overtreatment, while the clinician must still manage cardiovascular and kidney risk.

Integrated care also requires attention to mental health and caregiver burden. Depression, anxiety, pain, poor sleep and financial strain can make adherence harder even when medicines are available. A person-centered approach asks not only whether each guideline target is met, but whether the whole treatment plan is realistic, safe and understandable for the patient.

Frequently Asked Questions

Multimorbidity means having two or more long-term health conditions at the same time, such as diabetes plus heart disease, chronic lung disease, kidney disease or depression.

Medication reviews help identify duplicate therapy, drug interactions, side effects and medicines that may no longer match the patient's current goals or health status.

No. Qualitative studies are designed to understand experiences, barriers and care processes; they are most useful for improving systems and generating questions for further research.

References

  1. Scientific Reports. A longitudinal qualitative study on physician experience in managing multimorbidity across the COVID-19 pandemic in Odisha, India. 2026.
  2. World Health Organization. Noncommunicable diseases fact sheet. 25 September 2025.
  3. World Health Organization. Framework on integrated, people-centred health services. 2016.